Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3

被引:253
作者
Pendergraft, WF
Preston, GA
Shah, RR
Tropsha, A
Carter, CW
Jennette, JC
Falk, RJ [1 ]
机构
[1] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Div Nephrol & Hypertens, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Sch Pharm, Lab Mol Modeling, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Dept Biochem, Chapel Hill, NC 27599 USA
关键词
D O I
10.1038/nm968
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It remains unclear how and why autoimmunity occurs. Here we show evidence for a previously unrecognized and possibly general mechanism of autoimmunity. This new finding was discovered serendipitously using material from patients with inflammatory vascular disease caused by antineutrophil cytoplasmic autoantibodies (ANCA) with specificity for proteinase-3 (PR-3). Such patients harbor not only antibodies to the autoantigen (PR-3), but also antibodies to a peptide translated from the antisense DNA strand of PR-3 (complementary PR-3, cPR-3) or to a mimic of this peptide. Immunization of mice with the middle region of cPR-3 resulted in production of antibodies not only to cPR-3, but also to the immunogen's sense peptide counterpart, PR-3. Both human and mouse antibodies to PR-3 and cPR-3 bound to each other, indicating idiotypic relationships. These findings indicate that autoimmunity can be initiated through an immune response against a peptide that is antisense or complementary to the autoantigen, which then induces anti-idiotypic antibodies (autoantibodies) that cross-react with the autoantigen.
引用
收藏
页码:72 / 79
页数:8
相关论文
共 61 条
[1]  
Araga S, 1999, J IMMUNOL, V163, P476
[2]   PREVENTION OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS BY MANIPULATION OF THE IMMUNE NETWORK WITH A COMPLEMENTARY PEPTIDE FOR THE ACETYLCHOLINE-RECEPTOR [J].
ARAGA, S ;
LEBOEUF, RD ;
BLALOCK, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) :8747-8751
[3]  
Araga S, 1994, Immunomethods, V5, P130, DOI 10.1006/immu.1994.1047
[4]   A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell help [J].
Araga, S ;
Xu, LK ;
Nakashima, K ;
Villain, M ;
Blalock, JE .
FASEB JOURNAL, 2000, 14 (01) :185-196
[5]  
Araga S, 1996, J IMMUNOL, V157, P386
[6]   THE ANTISENSE HOMOLOGY BOX - A NEW MOTIF WITHIN PROTEINS THAT ENCODES BIOLOGICALLY-ACTIVE PEPTIDES [J].
BARANYI, L ;
CAMPBELL, W ;
OHSHIMA, K ;
FUJIMOTO, S ;
BOROS, M ;
OKADA, H .
NATURE MEDICINE, 1995, 1 (09) :894-901
[7]   Autoimmunity - The pathogen connection [J].
Benoist, C ;
Mathis, D .
NATURE, 1998, 394 (6690) :227-228
[8]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[9]   Did tRNA synthetase classes arise on opposite strands of the same gene? [J].
Carter, CW ;
Duax, WL .
MOLECULAR CELL, 2002, 10 (04) :705-708
[10]   ANTIBODIES AGAINST GRANULE PROTEINS ACTIVATE NEUTROPHILS INVITRO [J].
CHARLES, LA ;
CALDAS, MLR ;
FALK, RJ ;
TERRELL, RS ;
JENNETTE, JC .
JOURNAL OF LEUKOCYTE BIOLOGY, 1991, 50 (06) :539-546